Selected research
Market Analysis & Forecast
Global Onsite Medical Market Analysis and Forecast 2026-2032
Market perspective
The global Onsite Medical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Onsite Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Onsite Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Onsite Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Onsite Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Onsite Medical include Mobile Medical Corporation, QuadMed, HSP Group, Medcor, Eden Health, ProgressiveHealth, Work Health Solutions, MedExpress and OnSite Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Onsite Medical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Onsite Medical, also provides the revenue of main regions and countries. Of the upcoming market potential for Onsite Medical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Onsite Medical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Onsite Medical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Onsite Medical revenue, projected growth trends, production technology, application and end-user industry.
Onsite Medical Segment by Company
Mobile Medical Corporation
QuadMed
HSP Group
Medcor
Eden Health
ProgressiveHealth
Work Health Solutions
MedExpress
OnSite Health
NeoPath
Concentra
CareATC
Premise Health
PMR Healthcare
WorkCare
Onsite Medical Segment by Type
Health Examination
Acute Care
Primary Health Care
Others
Onsite Medical Segment by Application
School
Enterprise
Building Site
Others
Onsite Medical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Onsite Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Onsite Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Onsite Medical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Onsite Medical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Onsite Medical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Onsite Medical revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Health Examination
- Acute Care
- Primary Health Care
- Others
Applications
- School
- Enterprise
- Building Site
- Others
Companies covered
- Mobile Medical Corporation
- QuadMed
- HSP Group
- Medcor
- Eden Health
- ProgressiveHealth
- Work Health Solutions
- MedExpress
- OnSite Health
- NeoPath
- Concentra
- CareATC
- Premise Health
- PMR Healthcare
- WorkCare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Onsite Medical Market by Type
- 1.2.1 Global Onsite Medical Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Health Examination
- 1.2.3 Acute Care
- 1.2.4 Primary Health Care
- 1.2.5 Others
- 1.3 Onsite Medical Market by Application
- 1.3.1 Global Onsite Medical Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 School
- 1.3.3 Enterprise
- 1.3.4 Building Site
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Onsite Medical Market Dynamics
- 2.1 Onsite Medical Industry Trends
- 2.2 Onsite Medical Industry Drivers
- 2.3 Onsite Medical Industry Opportunities and Challenges
- 2.4 Onsite Medical Industry Restraints
3 Global Growth Perspective
- 3.1 Global Onsite Medical Market Perspective (2021-2032)
- 3.2 Global Onsite Medical Growth Trends by Region
- 3.2.1 Global Onsite Medical Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Onsite Medical Market Size by Region (2021-2026)
- 3.2.3 Global Onsite Medical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Onsite Medical Revenue by Players
- 4.1.1 Global Onsite Medical Revenue by Players (2021-2026)
- 4.1.2 Global Onsite Medical Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Onsite Medical Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Onsite Medical Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Onsite Medical Key Players Headquarters & Area Served
- 4.4 Global Onsite Medical Players, Product Type & Application
- 4.5 Global Onsite Medical Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Onsite Medical Market CR5 and HHI
- 4.6.3 2025 Onsite Medical Tier 1, Tier 2, and Tier 3
5 Onsite Medical Market Size by Type
- 5.1 Global Onsite Medical Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Onsite Medical Revenue by Type (2021-2032)
- 5.3 Global Onsite Medical Revenue Market Share by Type (2021-2032)
6 Onsite Medical Market Size by Application
- 6.1 Global Onsite Medical Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Onsite Medical Revenue by Application (2021-2032)
- 6.3 Global Onsite Medical Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Mobile Medical Corporation
- 7.1.1 Mobile Medical Corporation Company Information
- 7.1.2 Mobile Medical Corporation Business Overview
- 7.1.3 Mobile Medical Corporation Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.1.4 Mobile Medical Corporation Onsite Medical Product Portfolio
- 7.1.5 Mobile Medical Corporation Recent Developments
- 7.2 QuadMed
- 7.2.1 QuadMed Company Information
- 7.2.2 QuadMed Business Overview
- 7.2.3 QuadMed Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.2.4 QuadMed Onsite Medical Product Portfolio
- 7.2.5 QuadMed Recent Developments
- 7.3 HSP Group
- 7.3.1 HSP Group Company Information
- 7.3.2 HSP Group Business Overview
- 7.3.3 HSP Group Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.3.4 HSP Group Onsite Medical Product Portfolio
- 7.3.5 HSP Group Recent Developments
- 7.4 Medcor
- 7.4.1 Medcor Company Information
- 7.4.2 Medcor Business Overview
- 7.4.3 Medcor Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.4.4 Medcor Onsite Medical Product Portfolio
- 7.4.5 Medcor Recent Developments
- 7.5 Eden Health
- 7.5.1 Eden Health Company Information
- 7.5.2 Eden Health Business Overview
- 7.5.3 Eden Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.5.4 Eden Health Onsite Medical Product Portfolio
- 7.5.5 Eden Health Recent Developments
- 7.6 ProgressiveHealth
- 7.6.1 ProgressiveHealth Company Information
- 7.6.2 ProgressiveHealth Business Overview
- 7.6.3 ProgressiveHealth Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.6.4 ProgressiveHealth Onsite Medical Product Portfolio
- 7.6.5 ProgressiveHealth Recent Developments
- 7.7 Work Health Solutions
- 7.7.1 Work Health Solutions Company Information
- 7.7.2 Work Health Solutions Business Overview
- 7.7.3 Work Health Solutions Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.7.4 Work Health Solutions Onsite Medical Product Portfolio
- 7.7.5 Work Health Solutions Recent Developments
- 7.8 MedExpress
- 7.8.1 MedExpress Company Information
- 7.8.2 MedExpress Business Overview
- 7.8.3 MedExpress Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.8.4 MedExpress Onsite Medical Product Portfolio
- 7.8.5 MedExpress Recent Developments
- 7.9 OnSite Health
- 7.9.1 OnSite Health Company Information
- 7.9.2 OnSite Health Business Overview
- 7.9.3 OnSite Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.9.4 OnSite Health Onsite Medical Product Portfolio
- 7.9.5 OnSite Health Recent Developments
- 7.10 NeoPath
- 7.10.1 NeoPath Company Information
- 7.10.2 NeoPath Business Overview
- 7.10.3 NeoPath Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.10.4 NeoPath Onsite Medical Product Portfolio
- 7.10.5 NeoPath Recent Developments
- 7.11 Concentra
- 7.11.1 Concentra Company Information
- 7.11.2 Concentra Business Overview
- 7.11.3 Concentra Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.11.4 Concentra Onsite Medical Product Portfolio
- 7.11.5 Concentra Recent Developments
- 7.12 CareATC
- 7.12.1 CareATC Company Information
- 7.12.2 CareATC Business Overview
- 7.12.3 CareATC Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.12.4 CareATC Onsite Medical Product Portfolio
- 7.12.5 CareATC Recent Developments
- 7.13 Premise Health
- 7.13.1 Premise Health Company Information
- 7.13.2 Premise Health Business Overview
- 7.13.3 Premise Health Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.13.4 Premise Health Onsite Medical Product Portfolio
- 7.13.5 Premise Health Recent Developments
- 7.14 PMR Healthcare
- 7.14.1 PMR Healthcare Company Information
- 7.14.2 PMR Healthcare Business Overview
- 7.14.3 PMR Healthcare Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.14.4 PMR Healthcare Onsite Medical Product Portfolio
- 7.14.5 PMR Healthcare Recent Developments
- 7.15 WorkCare
- 7.15.1 WorkCare Company Information
- 7.15.2 WorkCare Business Overview
- 7.15.3 WorkCare Onsite Medical Revenue and Gross Margin (2021-2026)
- 7.15.4 WorkCare Onsite Medical Product Portfolio
- 7.15.5 WorkCare Recent Developments
8 North America
- 8.1 North America Onsite Medical Revenue (2021-2032)
- 8.2 North America Onsite Medical Revenue by Type (2021-2032)
- 8.2.1 North America Onsite Medical Revenue by Type (2021-2026)
- 8.2.2 North America Onsite Medical Revenue by Type (2027-2032)
- 8.3 North America Onsite Medical Revenue Share by Type (2021-2032)
- 8.4 North America Onsite Medical Revenue by Application (2021-2032)
- 8.4.1 North America Onsite Medical Revenue by Application (2021-2026)
- 8.4.2 North America Onsite Medical Revenue by Application (2027-2032)
- 8.5 North America Onsite Medical Revenue Share by Application (2021-2032)
- 8.6 North America Onsite Medical Revenue by Country
- 8.6.1 North America Onsite Medical Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Onsite Medical Revenue by Country (2021-2026)
- 8.6.3 North America Onsite Medical Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Onsite Medical Revenue (2021-2032)
- 9.2 Europe Onsite Medical Revenue by Type (2021-2032)
- 9.2.1 Europe Onsite Medical Revenue by Type (2021-2026)
- 9.2.2 Europe Onsite Medical Revenue by Type (2027-2032)
- 9.3 Europe Onsite Medical Revenue Share by Type (2021-2032)
- 9.4 Europe Onsite Medical Revenue by Application (2021-2032)
- 9.4.1 Europe Onsite Medical Revenue by Application (2021-2026)
- 9.4.2 Europe Onsite Medical Revenue by Application (2027-2032)
- 9.5 Europe Onsite Medical Revenue Share by Application (2021-2032)
- 9.6 Europe Onsite Medical Revenue by Country
- 9.6.1 Europe Onsite Medical Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Onsite Medical Revenue by Country (2021-2026)
- 9.6.3 Europe Onsite Medical Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Onsite Medical Revenue (2021-2032)
- 10.2 China Onsite Medical Revenue by Type (2021-2032)
- 10.2.1 China Onsite Medical Revenue by Type (2021-2026)
- 10.2.2 China Onsite Medical Revenue by Type (2027-2032)
- 10.3 China Onsite Medical Revenue Share by Type (2021-2032)
- 10.4 China Onsite Medical Revenue by Application (2021-2032)
- 10.4.1 China Onsite Medical Revenue by Application (2021-2026)
- 10.4.2 China Onsite Medical Revenue by Application (2027-2032)
- 10.5 China Onsite Medical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Onsite Medical Revenue (2021-2032)
- 11.2 Asia Onsite Medical Revenue by Type (2021-2032)
- 11.2.1 Asia Onsite Medical Revenue by Type (2021-2026)
- 11.2.2 Asia Onsite Medical Revenue by Type (2027-2032)
- 11.3 Asia Onsite Medical Revenue Share by Type (2021-2032)
- 11.4 Asia Onsite Medical Revenue by Application (2021-2032)
- 11.4.1 Asia Onsite Medical Revenue by Application (2021-2026)
- 11.4.2 Asia Onsite Medical Revenue by Application (2027-2032)
- 11.5 Asia Onsite Medical Revenue Share by Application (2021-2032)
- 11.6 Asia Onsite Medical Revenue by Country
- 11.6.1 Asia Onsite Medical Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Onsite Medical Revenue by Country (2021-2026)
- 11.6.3 Asia Onsite Medical Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Onsite Medical Revenue (2021-2032)
- 12.2 SAMEA Onsite Medical Revenue by Type (2021-2032)
- 12.2.1 SAMEA Onsite Medical Revenue by Type (2021-2026)
- 12.2.2 SAMEA Onsite Medical Revenue by Type (2027-2032)
- 12.3 SAMEA Onsite Medical Revenue Share by Type (2021-2032)
- 12.4 SAMEA Onsite Medical Revenue by Application (2021-2032)
- 12.4.1 SAMEA Onsite Medical Revenue by Application (2021-2026)
- 12.4.2 SAMEA Onsite Medical Revenue by Application (2027-2032)
- 12.5 SAMEA Onsite Medical Revenue Share by Application (2021-2032)
- 12.6 SAMEA Onsite Medical Revenue by Country
- 12.6.1 SAMEA Onsite Medical Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Onsite Medical Revenue by Country (2021-2026)
- 12.6.3 SAMEA Onsite Medical Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst